Caption: Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes Credit: Market Research Reports, Inc. Related Press Releases Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes; New Report Launched Link to this Photo Email & IM: Direct Link: HTML Code: IMG Code: Download Photo High Resolution Screen Resolution Medium Resolution Small Resolution Thumbnail Resolution Download Photo Information Source: Market Research Reports, Inc. Release date: Wednesday Sep 14, 2016 Release time: 04:12 am Width:: 1203px Height:: 852px Size:: 213 KB Share